Skip to content
WeighLab
Menu
Ranked #158 · Grade C

Medro review

Medro (Medro Health Technologies, Inc.) is a telehealth brand whose GLP-1 program offers compounded semaglutide and tirzepatide, plus brand-name GLP-1s when eligible, via a partner medical group and…

Visit Medro Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$199/mo (compounded)
Tirzepatide
$299/mo (compounded)
Coverage
All 50 states
Brand-name
Yes

Semaglutide · modeled / year

$2,388

Tirzepatide · modeled / year

$3,588

The Index scorecard

Medro scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month55/100
Price Transparency62/100
Nationwide Access86/100
Formulation Options79/100
Clinical Oversight71/100
Contract Flexibility33/100

Where the value is

  • Covers both compounded semaglutide and tirzepatide and can prescribe brand-name GLP-1s when clinically appropriate.
  • LegitScript-certified (seal #50716646), available in all 50 states, with tiered pricing shown before checkout.
  • No membership fee and free expedited shipping on all orders; online intake with no appointment required in many cases.
  • Prices drop with longer commitments (semaglutide to $149/mo, tirzepatide to $224/mo on a 12-month plan).

The tradeoffs

  • Does not name its compounding pharmacy or its clinical partner medical group, so the fulfillment chain is not verifiable.
  • Pricing is described as illustrative and may change by dose, pharmacy availability, and eligibility — final cost shows only at checkout.
  • Very new brand (2026, trademark pending) spanning many verticals, with a short track record in GLP-1 care.
  • Compounded medications are not FDA-approved or therapeutically equivalent to Ozempic, Wegovy, Mounjaro, or Zepbound.

The bottom line

Best for: Cost-first shoppers who want compounded or brand semaglutide/tirzepatide with transparent tiered pricing and no membership, all 50 states. Medro (Medro Health Technologies, Inc.) is a telehealth brand whose GLP-1 program offers compounded semaglutide and tirzepatide, plus brand-name GLP-1s when eligible, via a partner medical group and…

Ranked #158 of 492 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 491 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Medro.

The 18 programs nearest this one

Pricing, states and verification reflect Medro's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Medro's site. Not medical advice; see our disclosure.

← Back to the value leaderboard